Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 801 results for "lymphocyte count"

High T-Cell Counts Make Better Match for Stem-Cell Transplants

Image: Scanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor (Photo courtesy of The National Institute of Allergy and Infectious Diseases). A simple blood test that measures the T ... Lab Medica, 6 days ago
[x]  

3 images for "lymphocyte count"

MDLinx, 6 days ago
MDLinx, 2 weeks ago
MDLinx, 1 month ago

Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression

Background: Current treatment guidelines for HIV infection recommend routine CD4 + lymphocyte (CD4) count monitoring in patients with viral suppression. This may have a limited impact on influencing care as clinically meaningful CD4 decline rarely ...
 JAIDS2 weeks ago

TG Therapeutics announces encouraging results from Phase II CLL study

TG-1101 also appeared to abrogate ibrutinib related lymphocytosis with patients experiencing a median 75% reduction in their absolute lymphocyte count (ALC) by the end of month 3 following initiation of combination therapy and 70% of patients ...
 Individual.com4 days ago

An unusual case of severe anaemia and lymphocytosis

S J Chavda , specialist registrar, haematology, National Institute for Health Research academic clinical fellow 1 , S Iyengar , consultant in haematology 1 , C Dearden , consultant in haematology 1 1 Department of Haemato-Oncology, Royal Marsden NHS ...
 British Medical Journal1 month ago
EuroInvestor

Novartis drug Arzerra® improved median progression-free survival by 54% in patients with relapsed chronic lymphocytic leukemia

Novartis International AG / Novartis drug Arzerra® improved median progression-free survival by 54% in patients with relapsed chronic lymphocytic leukemia . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely ...
 EuroInvestor3 weeks ago Novartis drug Arzerra(R) improved median progression-free survival by 54% in patients with relapsed chronic lymphocytic leukemia  Individual.com3 weeks ago NOVARTIS : drug Arzerra® improved median progression-free survival by 54% in patients with relapsed chronic lymphocytic leukemia  4 Traders3 weeks ago ACTELION : New data supporting gradual up-titration of ponesimod to mitigate first-dose cardiodynamic effects to be presented at EACPT 2015  4 Traders1 week ago
[x]  

Zydelig® in Combination With Ofatumumab Improves Progression-Free Survival in Previously-Treated Patients With Chronic Lymphocytic Leukemia

Gilead Sciences, Inc. ( Nasdaq:GILD ) today announced results from the Phase 3 clinical Study 119 of an investigational use of Zydelig ® (idelalisib) in combination with ofatumumab in previously-treated patients with chronic ...
 Marketplace1 month ago Zydelig in Combination With Ofatumumab Improves Progression-Free Survival in Previously-Treated Patients With Chronic Lymphocytic Leukemia  Pharmacy Choice1 month ago CLL: Ibrutinib Combo Significantly Extends Progression-free Survival in Treatment-Resistant Patients  Oncology Times2 weeks ago Time to Progression in CLL Improves 80 Percent with Imbruvica Plus Standard Drugs  CURE Magazine1 month ago
[x]  

Infinity Reports Phase 1 Data Showing Clinical Activity of Duvelisib in Treatment-Nave Patients with Chronic Lymphocytic Leukemia

Source: Infinity Pharmaceuticals, Inc. CAMBRIDGE, Mass.(BUSINESS WIRE)Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) today announced new clinical data for duvelisib (IPI-145), an oral, dual inhibitor of phosphoinositide-3-kinase (PI3K)-delta and ...
 Pharma Voice4 weeks ago Infinity Pharmaceuticals announces encouraging data from Phase I CLL study  Individual.com3 weeks ago Infinity Pharmaceuticals Inc. Reports Phase 1 Data Showing Clinical Activity Of Duvelisib In Treatment-Na??ve Patients With Chronic Lymphocytic Leukemia  BioSpace1 month ago INFINITY PHARMACEUTICALS : Reports Phase 1 Data Showing Clinical Activity of Duvelisib in Treatment-Nave Patients with Chronic Lymphocytic Leukemia  4 Traders1 month ago
[x]  

Quebec becomes the first province to fund GAZYVA® for patients with most common form of leukemia[1]

Targeted treatment to be added to Quebec's drug benefit formulary for patients with Chronic Lymphocytic Leukemia MISSISSAUGA, ON, June 2, 2015 /CNW/ -People in Quebec living with Chronic Lymphocytic Leukemia (CLL) will now be able to access a new ...
 Reliance Trust1 month ago
[x]  
Sys-Con Media

Patients in Manitoba and Saskatchewan living with the most common form of leukemia[1] now have access to a targeted treatment option

GAZYVA® to be reimbursed in Manitoba and Saskatchewan for patients with Chronic Lymphocytic Leukemia MISSISSAUGA, ON, July 6, 2015 /CNW/ - People in Manitoba and Saskatchewan living with Chronic Lymphocytic Leukemia (CLL) will now be able to ...
 TickerTech.com1 day ago
[x]  
MedPage Today

ASCO 2015: Obinutuzumab doubles remission duration in patients with relapsed, indolent non-hodgkin lymphoma

Interim analysis of a phase III study finds that adding the new anti-CD20 monoclonal antibody obinutuzumab to standard bendamustine chemotherapy significantly delays progression of indolent non-Hodgkin lymphoma (NHL). Among patients for whom ...
 Ecancer Medicalscience1 month ago Obinutuzumab Doubles Remission Duration in Patients With Relapsed, Indolent Non-Hodgkin Lymphoma  FiercePharma1 month ago Promising Results for NHL Patients Refractory to Rituximab: Obinutuzumab-Bendamustine Combination Doubles Remission Duration  Oncology Times1 week ago ASCO: Gazyva Doubles Average Remission Time in NHL  MedPage Today1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less